Plano-based PX Technology, a pioneer in digitizing healthcare processes, has been acquired by Maryland-based CareMetx, a technology-enabled hub services platform that facilitates patient access to specialty medications.
“Joining forces with CareMetx propels us towards a future where technological innovation and comprehensive provider and patient support converge to redefine healthcare delivery,” PX Technology CEO Michael Sullivan said in a statement. “Together, we’re set to expand our impact, ensuring that navigating the healthcare system becomes easier and more provider- and patient-centric than ever before.”
Terms of the acquisition were not disclosed.
CareMetx said that via the acquisition, it wants to reshape the landscape of specialty medication access and transform patient care by combining its comprehensive patient support services with PX Technology’s innovative digital access technologies and network, delivering synergies, value, and transparency to patients, providers, and manufacturers.
PX Technology was founded in 2019 and leverages proprietary technology to connect patients, providers, and partners.
Its suite of digital solutions, including PX Connect, PX ePA, and PX Consent, support healthcare providers in tasks such as streamlining the patient enrollment process, offering customized technology that integrates into existing workflows and “significantly reduces administrative burden.”
Building on a prior partnership
CareMetx and PX Technology said they have partnered closely for the past five years, piloting and improving methods to boost patient access to specialty therapies.
CareMetx said that with the addition of PX Technology’s innovative technology to its digital hub platform, the new combined business will aim to further address the complexities of obtaining specialty medications by enhancing the entire patient care journey, from prescription initiation to adherence in a seamless, efficient, and patient-centered process.
“Our union with PX Technology follows years of close partnership and collaboration and marks a significant leap forward in CareMetx’s mission to dismantle the barriers that stand between patients and the essential therapies they need,” CareMetx President and CEO Jim Rowe said in a statement. “By bringing together our strengths and shared values, we are uniquely positioned to drive greater efficiency in provider workflows while also ensuring that patients receive their treatments without unnecessary delay.”
CareMetx said the acquisition also brings together its expansive support services with PX Technology’s extensive network, offering pharmaceutical companies unparalleled access and visibility into the practices of more than 1,300 healthcare providers.
The acquisition is expected to enhance the connection between pharmaceutical manufacturers and healthcare providers, improving the speed and transparency of the specialty medication delivery process. CareMetx said that providers will benefit from an enhanced portfolio of accessible therapies, instant benefit verifications, and the opportunity for more same-day treatment decisions.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Here’s how your company could be named one of the most innovative, fastest-growing companies in North America. The prestigious Fast 500 rankings honor companies large and small, public and private. Time is ticking: Apply by June 23, 2023.
-
Mobility startups from coast to coast—including those focused on innovative ideas to transport people or goods—are invited to apply. The unique accelerator program supports startups in the automotive ecosystem, ranging from AI-powered industry solutions and transportation infrastructure to dealer support and related services.
-
The Dallas-based serial entrepreneur and business exec will share his take on the impact of mentorship at the awards event in September. His storied career, which includes a successful turnaround of Kinkos and its sale to FedEx, spans retail and gaming to cosmetics and private equity. Nominations for mentors opened on August 20.
-
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
-
With its new Dallas headquarters, fresh identity, and a mission to amplify "fan insights," Leap is set to integrate Epic's invaluable "experiential e-commerce data" into its comprehensive range of solutions.
